Morgan Stanley Knock-Out BYW6/ DE000ME8FLD2 /
29/05/2024 18:20:11 | Chg.- | Bid08:00:28 | Demandez à08:00:28 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.930EUR | - | 0.930 Bid taille: 1,000 |
0.970 Ask la taille: 1,000 |
BAYWA AG VINK.NA. O.... | 31.5643 EUR | 31/12/2078 | Put |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page